
Emtrix S 250mg/125mg Injection
Marketer
Sarthi Life Sciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Emtrix S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration of Combiflox 250mg/125mg Injection must be under medical guidance. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Minor side effects, such as nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe or worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (skin rashes, itching, swelling, respiratory distress). Inform your physician about all current medications before commencing treatment. Expectant or nursing mothers should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Sufficient rest, a nutritious diet, and ample hydration are recommended for optimal recovery. Your physician may order tests to monitor the medication's effects.
Uses of Emtrix S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Emtrix S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Emtrix S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Emtrix S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Emtrix S 250mg/125mg Injection works:
The injectable formulation Emtrix S, containing 250mg Ceftriaxone and 125mg Sulbactam, combines an antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, vital for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Emtrix S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Emtrix S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Emtrix S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Emtrix S 250mg/125mg can reduce awareness, impair vision, and induce drowsiness or dizziness. Refrain from driving while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Emtrix S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
The use of Emtrix S 250mg/125mg Injection requires careful consideration in individuals with advanced liver impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Emtrix S 250mg/125mg Injection dosage is not suggested for those experiencing mild or moderately compromised liver function.
What if you forget to take Emtrix S 250mg/125mg Injection :
Should you forget a scheduled dose of Emtrix S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Emtrix S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
